Search Results 281-290 of 16955 for ozempic

  1. Ependymoma - Doctors and departments - Mayo Clinic

    Learn about this tumor that forms from ependymal cells in the brain and spinal cord. Treatments include surgery, radiation therapy and chemotherapy.

  2. Belzutifan (oral route) - Side effects & dosage - Mayo Clinic

    Belzutifan is used to treat von Hippel-Lindau (VHL) disease in patients who need treatment for kidney cancer (renal cell carcinoma), brain and spinal cord ...

  3. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

    About this study. RATIONALE: Drugs used in chemotherapy, such as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells, ...

  4. How to save a life donating your blood stem cells - Mayo Clinic

    But some patients can't find a match in their family. Just about anyone can register. Most donors are under age 60; a simple cheek swab DNA test starts the ...

  5. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

  6. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Giving ixazomib with pomalidomide and dexamethasone may be an effective treatment for relapsed or relapsed/refractory multiple myeloma. Participation ...

  7. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of depemokimab 200 mg subcutaneous (SC) given every 6 months versus placebo in participants with ...

  8. A Study To Investigate The Efficacy And Safety Of Bemdaneprocel In Adults Who Have Parkinson's Disease - Mayo Clinic

    About this study. Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of ...

  9. Sevabertinib (oral route) - Side effects & dosage - Mayo Clinic

    Your doctor will perform a test before you take this medicine. Sevabertinib belongs to the group of medicines called antineoplastics (cancer medicines). It ...

  10. Ombitasvir, paritaprevir, ritonavir and dasabuvir (oral route) - Side effects & dosage - Mayo Clinic

    Ombitasvir, paritaprevir, ritonavir, and dasabuvir combination is used with or without ribavirin to treat chronic hepatitis C infection, including patients with ...